LE 6 REVIEW BOOK HEMA Flashcards

1
Q
  1. A 5-year-old child presents with petechiae and easy bruising following a recent viral infection. His platelet count is 30,000/µL. What is the most likely diagnosis?
    A. Heparin-induced thrombocytopenia (HIT)
    B. Immune thrombocytopenic purpura (ITP)
    C. Disseminated intravascular coagulation (DIC)
    D. Thrombotic thrombocytopenic purpura (TTP)
A

B. Immune thrombocytopenic purpura (ITP)

Rationale: ITP is the most common cause of thrombocytopenia in children, often following a viral infection. It is an autoimmune disorder where antibodies target platelets, leading to their destruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. A patient with cirrhosis and splenomegaly is found to have a platelet count of 90,000/µL. What is the most likely mechanism of thrombocytopenia in this patient?
    A. Increased platelet destruction
    B. Bone marrow failure
    C. Platelet sequestration
    D. Drug-induced thrombocytopenia
A

C. Platelet sequestration

Rationale: Splenomegaly leads to platelet sequestration, reducing circulating platelet count. This is commonly seen in liver cirrhosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. A hospitalized patient on heparin develops a drop in platelet count from 200,000/µL to 80,000/µL over 5 days. Which of the following is the most likely diagnosis?
    A. Heparin-induced thrombocytopenia (HIT)
    B. Thrombotic thrombocytopenic purpura (TTP)
    C. Disseminated intravascular coagulation (DIC)
    D. Immune thrombocytopenic purpura (ITP)
A

A. Heparin-induced thrombocytopenia (HIT)

Rationale: HIT is a prothrombotic disorder characterized by a drop in platelet count 5-10 days after heparin exposure. It paradoxically increases clotting risk rather than bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. Which of the following conditions causes both excessive clotting and bleeding due to widespread activation of coagulation pathways?
    A. Immune thrombocytopenic purpura (ITP)
    B. Disseminated intravascular coagulation (DIC)
    C. Essential thrombocythemia
    D. Von Willebrand disease
A

B. Disseminated intravascular coagulation (DIC)

Rationale: DIC results in widespread clot formation, leading to consumption of clotting factors and platelets, causing bleeding. It is seen in sepsis, trauma, and malignancies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. A 60-year-old woman with anemia due to chronic gastrointestinal bleeding is found to have a platelet count of 600,000/µL. What is the most likely cause of her thrombocytosis?
    A. Polycythemia vera
    B. Essential thrombocythemia
    C. Reactive thrombocytosis
    D. Chronic myeloid leukemia
A

C. Reactive thrombocytosis

Rationale: Reactive thrombocytosis occurs secondary to conditions such as infection, inflammation, malignancy, or iron deficiency anemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Essential thrombocythemia is associated with which of the following complications?
    A. Increased risk of clotting
    B. Increased risk of bleeding
    C. Both clotting and bleeding risk
    D. No significant complications
A

C. Both clotting and bleeding risk

Rationale: While thrombocytosis generally increases clotting risk, extremely high platelet counts (>1.5 million) can lead to bleeding due to acquired von Willebrand disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. A child with a history of easy bruising and mucosal bleeding has a defect in platelet aggregation due to the absence of Gp IIb/IIIa receptors. What is the most likely diagnosis?
    A. Bernard-Soulier Syndrome
    B. Glanzmann’s Thrombasthenia
    C. Von Willebrand Disease
    D. Storage Pool Disorder
A

B. Glanzmann’s Thrombasthenia

Rationale: Glanzmann’s Thrombasthenia is caused by a deficiency of the Gp IIb/IIIa receptor, leading to impaired platelet aggregation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. A patient with a history of mucosal bleeding and prolonged bleeding time is found to have a defect in platelet adhesion due to an absence of Gp Ib-IX-V receptors. What is the most likely diagnosis?
    A. Bernard-Soulier Syndrome
    B. Glanzmann’s Thrombasthenia
    C. Von Willebrand Disease
    D. Heparin-induced thrombocytopenia
A

A. Bernard-Soulier Syndrome

Rationale: Bernard-Soulier Syndrome is due to the absence of the Gp Ib-IX-V receptor, leading to defective platelet adhesion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. What is the most common inherited bleeding disorder that affects platelet adhesion?
    A. Glanzmann’s Thrombasthenia
    B. Bernard-Soulier Syndrome
    C. Von Willebrand Disease
    D. Storage Pool Disorder
A

C. Von Willebrand Disease

Rationale: Von Willebrand Disease (VWD) is the most common inherited bleeding disorder. It results from a deficiency or dysfunction of von Willebrand factor (vWF), which is necessary for platelet adhesion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. A 65-year-old man on daily aspirin therapy for cardiovascular protection is found to have an increased bleeding tendency. What is the mechanism behind this?
    A. Decreased platelet production
    B. Inhibition of platelet aggregation
    C. Increased platelet sequestration
    D. Activation of coagulation pathways
A

B. Inhibition of platelet aggregation

Rationale: Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), preventing thromboxane A2 synthesis, which is essential for platelet aggregation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
  1. A patient with chronic kidney disease has a prolonged bleeding time despite a normal platelet count. What is the most likely cause of this patient’s bleeding tendency?
    A. Deficiency of clotting factors
    B. Platelet sequestration in the spleen
    C. Uremia-induced platelet dysfunction
    D. Immune thrombocytopenic purpura (ITP)
A

C. Uremia-induced platelet dysfunction

Rationale: Uremia in chronic kidney disease impairs platelet adhesion and activation, leading to prolonged bleeding time despite a normal platelet count.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
  1. A 45-year-old man presents with recurrent episodes of epistaxis, GI bleeding, and visible telangiectasias on his lips and hands. He also has a family history of similar symptoms. What is the most likely diagnosis?
    A. Marfan Syndrome
    B. Hereditary Hemorrhagic Telangiectasia (HHT)
    C. Ehlers-Danlos Syndrome
    D. Scurvy
A

B. Hereditary Hemorrhagic Telangiectasia (HHT)

Rationale: HHT (Osler-Weber-Rendu syndrome) is an inherited disorder that leads to defective capillaries, causing telangiectasias, epistaxis, and GI bleeding. Arteriovenous malformations (AVMs) in the lungs, brain, and liver are also common.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. A 32-year-old woman with a history of hyperflexible joints and easy bruising presents with spontaneous bruises on her legs. She has hyperelastic skin and a history of mitral valve prolapse. What is the most likely diagnosis?
    A. Marfan Syndrome
    B. Hereditary Hemorrhagic Telangiectasia
    C. Ehlers-Danlos Syndrome
    D. Scurvy
A

C. Ehlers-Danlos Syndrome

Rationale: Ehlers-Danlos Syndrome (EDS) is a connective tissue disorder caused by defective collagen synthesis. It leads to hyperelastic skin, hypermobile joints, vessel fragility, and easy bruising.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
  1. A 25-year-old tall male with long limbs and a history of lens dislocation presents with aortic root dilation and easy bruising. Which of the following best explains his vascular disorder?
    A. Defective fibrillin-1 protein
    B. Deficiency of vitamin C
    C. Dysfunctional von Willebrand factor
    D. Decreased platelet count
A

A. Defective fibrillin-1 protein

Rationale: Marfan Syndrome is caused by mutations in the FBN1 gene, which encodes fibrillin-1, a key component of connective tissue. It affects large vessels, leading to aortic root dilation and dissection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q
  1. A 60-year-old man with a diet deficient in fruits and vegetables presents with bleeding gums, perifollicular hemorrhages, and corkscrew hair. Which of the following is the most likely underlying deficiency?
    A. Vitamin B12
    B. Vitamin C
    C. Vitamin K
    D. Iron
A

B. Vitamin C

Rationale: Scurvy is caused by vitamin C deficiency, leading to impaired collagen synthesis, resulting in fragile blood vessels, gingival bleeding, and perifollicular hemorrhages.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q
  1. A 68-year-old woman presents with recurrent ecchymoses on her forearms without a history of trauma. Her skin appears thin and fragile. She has no platelet abnormalities. What is the most likely diagnosis?
    A. Senile Purpura
    B. Disseminated Intravascular Coagulation (DIC)
    C. Heparin-Induced Thrombocytopenia (HIT)
    D. Ehlers-Danlos Syndrome
A

A. Senile Purpura

Rationale: Senile purpura is a benign condition seen in elderly individuals due to age-related capillary fragility and atrophy of the dermis. It is common on sun-exposed areas such as the forearms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
  1. A patient on long-term corticosteroid therapy develops easy bruising and thinning of the skin. What is the mechanism behind this vascular disorder?
    A. Impaired platelet function
    B. Inhibition of vitamin K-dependent clotting factors
    C. Atrophy of connective tissue supporting blood vessels
    D. Increased vascular inflammation
A

C. Atrophy of connective tissue supporting blood vessels

Rationale: Chronic corticosteroid use (as seen in Cushing’s Syndrome) leads to connective tissue atrophy, making blood vessels more fragile and prone to easy bruising.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q
  1. A peripheral blood smear shows giant platelets. This finding is characteristic of which disorder?
    A. Glanzmann’s Thrombasthenia
    B. Bernard-Soulier Syndrome
    C. Immune Thrombocytopenic Purpura (ITP)
    D. Disseminated Intravascular Coagulation (DIC)
A

B. Bernard-Soulier Syndrome

Rationale: Giant platelets are characteristic of Bernard-Soulier Syndrome, a platelet adhesion disorder due to a deficiency of Gp Ib-IX-V receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. A patient presents with thrombocytopenia, microangiopathic hemolytic anemia, and schistocytes on a peripheral smear. What is the most likely diagnosis?
    A. Disseminated Intravascular Coagulation (DIC)
    B. Thrombotic Thrombocytopenic Purpura (TTP)
    C. Immune Thrombocytopenic Purpura (ITP)
    D. Bernard-Soulier Syndrome
A

B. Thrombotic Thrombocytopenic Purpura (TTP)

Rationale: Schistocytes (fragmented RBCs) suggest microangiopathic hemolytic anemia, which occurs in TTP, DIC, and Hemolytic Uremic Syndrome (HUS). TTP is associated with thrombocytopenia, fever, neurological symptoms, renal dysfunction, and microangiopathic hemolytic anemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
  1. A platelet function test reveals an abnormal ristocetin test. Which of the following is the most likely diagnosis?
    A. Bernard-Soulier Syndrome
    B. Glanzmann’s Thrombasthenia
    C. Von Willebrand Disease
    D. Heparin-Induced Thrombocytopenia
A

C. Von Willebrand Disease

Rationale: An abnormal ristocetin test suggests von Willebrand Disease (VWD), a disorder affecting platelet adhesion due to vWF deficiency or dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q
  1. A platelet aggregation test shows an absence of aggregation with ADP and collagen but normal response to ristocetin. Which disorder does this indicate?
    A. Bernard-Soulier Syndrome
    B. Glanzmann’s Thrombasthenia
    C. Von Willebrand Disease
    D. Disseminated Intravascular Coagulation (DIC)
A

B. Glanzmann’s Thrombasthenia

Rationale: Glanzmann’s Thrombasthenia is a platelet aggregation disorder caused by a deficiency of Gp IIb/IIIa receptors. It results in absent aggregation with ADP and collagen but normal response to ristocetin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
  1. A bone marrow biopsy of a patient with pancytopenia shows hypocellular marrow. What is the most likely diagnosis?
    A. Myelodysplastic Syndrome
    B. Aplastic Anemia
    C. Disseminated Intravascular Coagulation
    D. Polycythemia Vera
A

B. Aplastic Anemia

Rationale: Aplastic anemia presents with pancytopenia and hypocellular bone marrow due to failure of hematopoiesis, often caused by autoimmune destruction or toxins.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
  1. A 5-year-old boy with recurrent painful episodes and jaundice presents with anemia and a peripheral smear showing sickle-shaped red blood cells. What is the underlying molecular defect?
    A. Glu6Lys mutation in β-globin
    B. Glu6Val mutation in β-globin
    C. β-globin mutation affecting splicing
    D. α-globin gene deletion
A

B. Glu6Val mutation in β-globin

Rationale: Sickle cell disease (SCD) results from a Glu6Val mutation in the β-globin gene, leading to HbS polymerization under deoxygenated conditions, causing RBC sickling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
  1. A patient with sickle cell disease presents with acute-onset chest pain, dyspnea, and fever. Chest X-ray shows pulmonary infiltrates. What is the most likely diagnosis?
    A. Acute chest syndrome
    B. Pulmonary embolism
    C. Bacterial pneumonia
    D. Mycoplasma pneumonia
A

A. Acute chest syndrome

Rationale: Acute chest syndrome (ACS) is a leading cause of mortality in sickle cell disease. It is triggered by vaso-occlusion in pulmonary vasculature, infections, or fat emboli.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
3. Which of the following is the first-line treatment for sickle cell disease to increase HbF levels? A. Methotrexate B. Hydroxyurea C. Erythropoietin D. Prednisone
B. Hydroxyurea Rationale: Hydroxyurea increases fetal hemoglobin (HbF), which inhibits HbS polymerization, reducing sickling and vaso-occlusive crises in sickle cell disease.
26
4. A patient’s hemoglobin electrophoresis shows >90% HbS. Which of the following is the most likely diagnosis? A. Sickle cell trait B. Sickle cell disease (HbSS) C. HbSC disease D. Hemoglobin C disease
B. Sickle cell disease (HbSS) Rationale: HbS >90% on electrophoresis is diagnostic for sickle cell disease (HbSS), whereas sickle cell trait (HbAS) has <50% HbS.
27
5. A 28-year-old African American man is found to have hemoglobin C disease on electrophoresis. Which characteristic finding is expected on his peripheral blood smear? A. Sickle cells B. Bite cells C. Target cells D. Acanthocytes
C. Target cells Rationale: HbC disease is characterized by target cells and mild hemolytic anemia. It results from a Glu6Lys mutation in β-globin.
28
9. A 24-year-old man develops hemolysis after eating fava beans. Peripheral smear shows bite cells and Heinz bodies. What is the underlying mechanism? A. Increased oxidative stress B. Reduced hemoglobin synthesis C. Impaired oxygen binding D. Defective globin chain production
A. Increased oxidative stress Rationale: Heinz body hemolytic anemia occurs when unstable hemoglobins or G6PD deficiency lead to oxidative damage, causing RBCs to form Heinz bodies and undergo extravascular hemolysis.
29
10. A 3-year-old child presents with cyanosis and chocolate-colored blood. Pulse oximetry is low, but oxygen therapy does not improve his symptoms. What is the most likely diagnosis? A. Carboxyhemoglobinemia B. Methemoglobinemia C. Sickle cell disease D. Hemoglobin E disease
B. Methemoglobinemia Rationale: Methemoglobinemia occurs when hemoglobin’s iron is oxidized to Fe³⁺ (ferric form), which cannot bind oxygen, leading to cyanosis and brownish blood.
30
1. A 25-year-old woman of Southeast Asian descent presents with mild anemia and microcytosis but has a normal iron panel. Hemoglobin electrophoresis is unremarkable. What is the most likely diagnosis? A. Beta thalassemia minor B. Alpha thalassemia trait C. Iron deficiency anemia D. Sideroblastic anemia
B. Alpha thalassemia trait Rationale: Alpha thalassemia trait (-α/-α or --/αα) presents with mild microcytic anemia but normal iron studies. Unlike beta thalassemia minor, Hb electrophoresis is often normal.
31
2. A newborn presents with hydrops fetalis and is found to have Hemoglobin Bart’s (γ₄) on hemoglobin electrophoresis. What is the underlying genetic defect? A. Deletion of all four α-globin genes B. Mutation in the β-globin gene C. Increased γ-globin chain production D. Hemoglobin instability
A. Deletion of all four α-globin genes Rationale: Hydrops fetalis (Hb Bart’s) results from complete deletion of α-globin genes (--/--), leading to γ₄ tetramers, which cannot carry oxygen.
32
4. A 2-year-old Mediterranean boy presents with pallor, hepatosplenomegaly, and growth retardation. Labs show severe microcytic anemia, target cells, and nucleated RBCs. Hemoglobin electrophoresis shows absent HbA and increased HbF. What is the most likely diagnosis? A. Beta thalassemia minor B. Beta thalassemia major C. Alpha thalassemia trait D. Hemoglobin H disease
B. Beta thalassemia major Rationale: Beta thalassemia major (Cooley’s anemia, β⁰/β⁰) results in severe anemia, hepatosplenomegaly, and absent HbA with increased HbF.
33
6. A 10-year-old boy with beta thalassemia major has received frequent blood transfusions. Which of the following complications is most concerning? A. Hemarthrosis B. Iron overload (hemochromatosis) C. Hemoglobinuria D. Splenic rupture
B. Iron overload (hemochromatosis) Rationale: Frequent transfusions in beta thalassemia major can cause iron overload, requiring iron chelation therapy (e.g., deferasirox, deferoxamine).
34
7. A skull X-ray of a child with beta thalassemia major shows a "crew-cut" appearance. What is the underlying cause? A. Skull fractures B. Extramedullary hematopoiesis C. Hemoglobin instability D. Iron deficiency
B. Extramedullary hematopoiesis Rationale: The "crew-cut" skull appearance results from marrow expansion due to chronic anemia, leading to extramedullary hematopoiesis.
35
8. Which of the following is the most definitive treatment for beta thalassemia major? A. Lifelong transfusions B. Hydroxyurea C. Bone marrow transplantation D. Iron chelation therapy
C. Bone marrow transplantation Rationale: Bone marrow transplantation is the only curative treatment for beta thalassemia major, though lifelong transfusions and iron chelation are the mainstays of management.
36
1. A 25-year-old man with sickle cell disease has mild symptoms despite having HbSS on genetic testing. Hemoglobin electrophoresis shows elevated HbF levels. What is the most likely explanation for his milder disease course? A. Coinheritance of alpha thalassemia B. Hereditary Persistence of Fetal Hemoglobin (HPFH) C. Iron deficiency anemia D. Sideroblastic anemia
B. Hereditary Persistence of Fetal Hemoglobin (HPFH) Rationale: HPFH results from HBB cluster deletions, leading to persistent fetal hemoglobin (HbF, α₂γ₂) production, which inhibits HbS polymerization and reduces sickling episodes.
37
4. A firefighter presents with headache, dizziness, and cherry-red skin after being in a burning building. What is the most likely diagnosis? A. Methemoglobinemia B. Carboxyhemoglobinemia C. Sulfhemoglobinemia D. Sickle cell crisis
B. Carboxyhemoglobinemia Rationale: CO poisoning occurs due to CO binding to Hb with high affinity, impairing oxygen transport. Classic signs include cherry-red skin, headache, dizziness.
38
9. Which of the following is the most common hemoglobinopathy worldwide? A. Sickle Cell Disease (HbS) B. Beta Thalassemia C. Alpha Thalassemia Trait D. Hemoglobin E (HbE)
D. Hemoglobin E (HbE) Rationale: HbE is the most common hemoglobin variant worldwide, especially in Southeast Asia.
39
10. The most common thalassemia globally is: A. Alpha thalassemia trait B. Beta thalassemia major C. Beta thalassemia minor D. Hemoglobin H disease
B. Beta thalassemia major Rationale: Beta thalassemia major is the most common severe thalassemia, requiring lifelong transfusions.
40
11. The most common cause of microcytic anemia worldwide is: A. Iron deficiency anemia B. Alpha thalassemia trait C. Beta thalassemia minor D. Anemia of chronic disease
A. Iron deficiency anemia Rationale: Iron deficiency anemia is the most common cause of microcytic anemia, but in Southeast Asia, alpha thalassemia trait is a frequent cause.
41
12. The most common cause of microcytic anemia in Southeast Asia is: A. Iron deficiency anemia B. Beta thalassemia minor C. Alpha thalassemia trait D. Hemoglobin H disease
C. Alpha thalassemia trait Rationale: Alpha thalassemia trait is highly prevalent in Southeast Asia and causes mild microcytosis.
42
1. Which of the following is NOT a common cause of iron deficiency anemia? A. Chronic gastrointestinal bleeding B. Heavy menstruation C. Increased erythropoiesis during pregnancy D. Hemolysis due to G6PD deficiency
D. Hemolysis due to G6PD deficiency Rationale: Hemolysis in G6PD deficiency does not lead to iron deficiency anemia because iron from lysed RBCs is recycled. Chronic blood loss, pregnancy, and menstruation are common causes of IDA.
43
2. A 45-year-old male presents with iron deficiency anemia but denies any history of blood loss. Which underlying condition should be ruled out first? A. Peptic ulcer disease B. Colon cancer C. Helicobacter pylori infection D. Vitamin B12 deficiency
B. Colon cancer Rationale: Occult gastrointestinal (GI) bleeding, especially from colon cancer, is a common cause of iron deficiency anemia in adult males and postmenopausal women.
44
3. A patient with Crohn’s disease and chronic diarrhea is found to have microcytic anemia. What is the most likely mechanism of their anemia? A. Increased blood loss B. Impaired iron absorption C. Increased iron demand D. Hemolysis
B. Impaired iron absorption Rationale: Crohn’s disease affects the small intestine, impairing iron absorption, leading to iron deficiency anemia.
45
4. In the early stage of iron deficiency (negative iron balance), which laboratory abnormality is expected? A. Low serum ferritin B. Low hemoglobin C. Increased mean corpuscular volume (MCV) D. Increased serum iron
A. Low serum ferritin Rationale: Serum ferritin (<15 µg/L) is the earliest marker of iron depletion, occurring before changes in serum iron or hemoglobin.
46
5. A patient's lab results show: Low serum iron (<30 µg/dL) Increased total iron-binding capacity (TIBC >360 µg/dL) Transferrin saturation <15% Which stage of iron deficiency is this patient in? A. Negative iron balance B. Iron-deficient erythropoiesis C. Iron deficiency anemia D. Megaloblastic anemia
B. Iron-deficient erythropoiesis Rationale: In iron-deficient erythropoiesis, iron levels are low, TIBC is increased, and transferrin saturation drops, but hemoglobin levels remain normal. TRANSFERRIN SATURATION: 20-15-10% -> IDA
47
6. A peripheral blood smear of a patient with severe iron deficiency anemia is most likely to show which characteristic feature? A. Macrocytic RBCs B. Howell-Jolly bodies C. Poikilocytes (pencil/cigar-shaped cells) D. Heinz bodies
C. Poikilocytes (pencil/cigar-shaped cells) Rationale: Iron deficiency anemia is associated with microcytic, hypochromic RBCs and pencil-shaped cells.
48
7. A 32-year-old woman presents with fatigue, pallor, and a craving for ice. She is most likely suffering from which of the following? A. Vitamin B12 deficiency B. Iron deficiency anemia C. Thalassemia minor D. Lead poisoning
B. Iron deficiency anemia Rationale: Pica (craving for ice, dirt, clay) is a classic symptom of iron deficiency anemia.
49
8. Which of the following is a unique symptom of iron deficiency anemia that is not typically seen in other causes of anemia? A. Fatigue and pallor B. Koilonychia (spoon nails) C. Glossitis D. Tachycardia
B. Koilonychia (spoon nails) Rationale: Koilonychia (spoon-shaped nails) is a classic sign of iron deficiency anemia, reflecting tissue hypoxia.
50
9. A patient with chronic iron deficiency anemia presents with dysphagia and esophageal webs. What is the most likely diagnosis? A. Wilson’s disease B. Plummer-Vinson syndrome C. Sjögren’s syndrome D. Peutz-Jeghers syndrome
B. Plummer-Vinson syndrome Rationale: Plummer-Vinson syndrome is a triad of iron deficiency anemia, dysphagia, and esophageal webs.
51
10. A patient with long-standing iron deficiency anemia reports an uncomfortable sensation in her legs at night, relieved by movement. Which of the following is the most likely diagnosis? A. Peripheral neuropathy B. Restless leg syndrome C. Fibromyalgia D. Vitamin B12 deficiency
B. Restless leg syndrome Rationale: Restless leg syndrome is associated with iron deficiency anemia, likely due to dopaminergic dysfunction.
52
1. A 65-year-old woman with rheumatoid arthritis presents with fatigue and pallor. Her lab results show: Serum iron: ↓ TIBC: ↓ Ferritin: Normal/↑ MCV: Normal What is the most likely diagnosis? A. Iron deficiency anemia B. Anemia of chronic disease C. Beta thalassemia minor D. Anemia of chronic kidney disease
B. Anemia of chronic disease Rationale: Anemia of chronic disease (ACD) is caused by increased hepcidin, leading to low iron, low TIBC, and normal or increased ferritin.
53
2. Which of the following best explains the pathophysiology of anemia of chronic inflammation? A. Increased erythropoietin production B. Decreased iron absorption from the intestine C. Increased hepcidin blocking iron release from macrophages D. Increased red blood cell (RBC) destruction
C. Increased hepcidin blocking iron release from macrophages Rationale: Hepcidin, stimulated by IL-6, inhibits ferroportin, preventing iron release from macrophages and enterocytes, reducing iron availability for erythropoiesis.
54
4. A 58-year-old male with chronic kidney disease stage 4 presents with anemia. Which of the following is the primary cause of his anemia? A. Increased hepcidin production B. Erythropoietin (EPO) deficiency C. Increased RBC destruction D. Iron overload
B. Erythropoietin (EPO) deficiency Rationale: CKD leads to decreased EPO production by the kidneys, resulting in reduced RBC production and normocytic anemia.
55
6. A 65-year-old CKD patient on hemodialysis develops worsening anemia. Which of the following is the most appropriate treatment? A. Oral iron supplements B. IV iron therapy C. Blood transfusions D. High-dose erythropoietin
B. IV iron therapy Rationale: Hemodialysis patients often have functional iron deficiency due to iron losses, requiring IV iron therapy rather than oral supplementation.
56
7. A 50-year-old woman with fatigue and weight gain is diagnosed with hypothyroidism. Her lab results show: Hb: 10.2 g/dL (low) MCV: Normal Reticulocyte count: Low TSH: High T4: Low What is the most likely cause of her anemia? A. Iron deficiency anemia B. Anemia of chronic disease C. Hypometabolic anemia due to hypothyroidism D. Beta thalassemia minor
C. Hypometabolic anemia due to hypothyroidism Rationale: Hypothyroidism leads to reduced erythropoiesis due to low EPO levels, causing normocytic anemia with a low reticulocyte count.
57
1. What is the most common leukemia in children, peaking at 3-4 years old? A. Acute Myeloid Leukemia (AML) B. Chronic Myeloid Leukemia (CML) C. Acute Lymphoblastic Leukemia (ALL) D. Chronic Lymphocytic Leukemia (CLL)
C. Acute Lymphoblastic Leukemia (ALL) Rationale: ALL is the most common childhood leukemia, peaking at 3-4 years of age, with a high cure rate in children.
58
2. Which cytogenetic abnormality is most commonly associated with older patients with B-lineage ALL? A. t(9;22) (Philadelphia chromosome, BCR-ABL1) B. t(15;17) (PML-RARA) C. t(8;21) (RUNX1-RUNX1T1) D. JAK2 mutation
A. t(9;22) (Philadelphia chromosome, BCR-ABL1) Rationale: The Philadelphia chromosome (BCR-ABL1) is more common in older adults and associated with poorer prognosis.
59
3. A child with ALL presents with pallor, petechiae, and recurrent infections. Which of the following best explains these findings? A. Organ infiltration B. Bone marrow failure C. Hemolysis D. Vitamin B12 deficiency
B. Bone marrow failure Rationale: Bone marrow infiltration by leukemic blasts leads to anemia (pallor, fatigue), thrombocytopenia (bleeding, petechiae), and neutropenia (recurrent infections).
60
4. A patient with ALL presents with headaches, vomiting, and cranial nerve palsies. What is the most likely cause? A. Hyperleukocytosis B. Meningeal leukemia (CNS involvement) C. Chemotherapy-induced neurotoxicity D. Metastatic disease
B. Meningeal leukemia (CNS involvement) Rationale: CNS involvement is a hallmark of ALL, requiring intrathecal chemotherapy for prophylaxis.
61
8. Which of the following is the gold standard for confirming the diagnosis of ALL? A. Peripheral blood smear B. Flow cytometry C. Bone marrow biopsy D. Serum LDH levels
C. Bone marrow biopsy Rationale: Bone marrow biopsy is required to confirm ALL, identify blast percentage, and classify the lineage.
62
9. Which of the following drugs is a tyrosine kinase inhibitor (TKI) used in Philadelphia chromosome-positive ALL? A. Rituximab B. Imatinib C. Methotrexate D. Cytarabine
B. Imatinib Rationale: Imatinib is a first-line TKI for Ph+ ALL. Other TKIs include Dasatinib and Nilotinib.
63
11. The most common site of relapse in ALL is: A. Bone marrow B. CNS C. Testes D. Liver
A. Bone marrow Rationale: Bone marrow is the most common relapse site, followed by CNS and testes.
64
12. Which of the following is a poor prognostic factor in ALL? A. Age 2-10 years B. WBC count <10,000/µL at diagnosis C. Minimal residual disease (MRD) positivity post-induction D. Presence of t(12;21) translocation
C. Minimal residual disease (MRD) positivity post-induction Rationale: MRD positivity after induction is a strong predictor of relapse and poor prognosis.
65
14. What is the approximate cure rate for childhood ALL with modern therapy? A. 50% B. 70% C. 90% D. 30%
C. 90% Rationale: Advances in treatment have increased childhood ALL cure rates to ~90%.
66
15. Which of the following groups has the poorest survival rate in ALL? A. Children (1-10 years) B. Adolescents (15-25 years) C. Adults 45-55 years D. Elderly (>55 years)
D. Elderly (>55 years) Rationale: Elderly patients (>55 years) have a <30% survival rate due to poor treatment tolerance and high-risk cytogenetics.
67
1. What is the most common leukemia in adults in Western countries? A. Acute Myeloid Leukemia (AML) B. Chronic Myeloid Leukemia (CML) C. Chronic Lymphocytic Leukemia (CLL) D. Acute Lymphoblastic Leukemia (ALL)
C. Chronic Lymphocytic Leukemia (CLL) Rationale: CLL is the most common leukemia in adults in Western countries, with a median diagnosis age of 71 years.
68
3. What is the most common initial presentation of CLL? A. Recurrent infections B. Lymphadenopathy C. Incidentally discovered lymphocytosis D. Splenomegaly
C. Incidentally discovered lymphocytosis Rationale: Most CLL cases are asymptomatic and diagnosed incidentally on routine blood work showing lymphocytosis (>5000 B cells/µL).
69
4. Which of the following symptoms in a patient with CLL indicates disease progression? A. Lymphocytosis B. Night sweats and weight loss C. Mild thrombocytopenia D. Fatigue
B. Night sweats and weight loss Rationale: B symptoms (fever, night sweats, weight loss) suggest advanced CLL and may indicate the need for treatment.
70
5. Which of the following cytogenetic abnormalities is associated with a favorable prognosis in CLL? A. del(13q) B. del(17p) C. trisomy 12 D. del(11q)
A. del(13q) Rationale: del(13q) (55%) is the most common cytogenetic abnormality in CLL and is associated with a favorable prognosis.
71
8. In the Rai staging system, what feature defines Stage IV CLL? A. Lymphocytosis only B. Lymphocytosis with lymphadenopathy C. Lymphocytosis with splenomegaly D. Lymphocytosis with thrombocytopenia (<100,000/µL)
D. Lymphocytosis with thrombocytopenia (<100,000/µL) Rationale: Stage IV CLL in the Rai staging system is defined by lymphocytosis with thrombocytopenia (<100,000/µL) and is considered high-risk.
72
9. A patient with CLL presents with rapid lymphocyte doubling time, hemoglobin 9.5 g/dL, and bulky lymphadenopathy. What is the next best step? A. Observation B. Start targeted therapy C. Bone marrow biopsy D. Intravenous immunoglobulin (IVIG)
B. Start targeted therapy Rationale: Indications for CLL treatment include rapid lymphocyte doubling (<6 months), symptomatic splenomegaly, cytopenias, and autoimmune complications.
73
10. Which of the following is a first-line therapy for most patients with CLL? A. Fludarabine + Cyclophosphamide + Rituximab (FCR) B. Ibrutinib C. Methotrexate D. Hydroxyurea
B. Ibrutinib Rationale: Ibrutinib (a BTK inhibitor) is preferred for most CLL patients, while FCR is used in select young, fit patients.
74
13. What is the most common cause of death in CLL patients? A. Infection B. Richter’s transformation C. Bone marrow failure D. Secondary malignancies
A. Infection Rationale: Hypogammaglobulinemia and neutropenia in CLL lead to recurrent infections, the leading cause of death (~50%).
75
14. A patient with CLL develops sudden worsening of lymphadenopathy and high-grade fever. Biopsy confirms large B-cell lymphoma. What is the diagnosis? A. Autoimmune hemolytic anemia B. Richter’s transformation C. Hodgkin lymphoma D. CML blast crisis
B. Richter’s transformation Rationale: Richter’s transformation is the progression of CLL to aggressive Diffuse Large B-cell Lymphoma (DLBCL) with poor prognosis.
76
1. Which of the following is the most common hematologic malignancy in adults? A. Acute Myeloid Leukemia (AML) B. Chronic Myeloid Leukemia (CML) C. Hodgkin’s Lymphoma (HL) D. Non-Hodgkin’s Lymphoma (NHL)
D. Non-Hodgkin’s Lymphoma (NHL) Rationale: NHL is the most common hematologic malignancy in adults and is 10 times more common than Hodgkin’s lymphoma (HL).
77
2. Which of the following is true regarding the epidemiology of NHL? A. More common in females B. Incidence peaks in childhood C. More common in Caucasians and increases with age D. Less common than Hodgkin’s lymphoma
C. More common in Caucasians and increases with age Rationale: NHL has a slight male predominance, is more common in Caucasians, and increases in incidence after age 40.
78
3. Epstein-Barr virus (EBV) infection is strongly associated with which subtype of NHL? A. Diffuse Large B-cell Lymphoma (DLBCL) B. Follicular Lymphoma C. Burkitt’s Lymphoma D. Marginal Zone Lymphoma
C. Burkitt’s Lymphoma Rationale: EBV infection is associated with Burkitt’s lymphoma, particularly in endemic (African) cases.
79
4. Which of the following infections is most strongly associated with gastric MALT lymphoma? A. Epstein-Barr Virus (EBV) B. Human T-cell Leukemia Virus-1 (HTLV-1) C. Helicobacter pylori D. Hepatitis C
C. Helicobacter pylori Rationale: Helicobacter pylori infection is a well-known risk factor for gastric MALT lymphoma, and eradication therapy can lead to remission.
80
5. Which of the following conditions is a strong risk factor for developing NHL? A. Rheumatoid arthritis B. Sjögren’s syndrome C. Hashimoto’s thyroiditis D. All of the above
D. All of the above Rationale: Autoimmune diseases such as Sjögren’s syndrome and Hashimoto’s thyroiditis increase the risk of NHL, particularly marginal zone lymphomas.
81
6. What is the most common clinical presentation of NHL? A. Painful lymphadenopathy B. Painless lymphadenopathy C. B symptoms only D. Hepatosplenomegaly without lymphadenopathy
B. Painless lymphadenopathy Rationale: Painless lymphadenopathy is the most common presentation of NHL and is frequently detected in the cervical, axillary, or inguinal lymph nodes.
82
7. A patient with NHL presents with fever, night sweats, and weight loss. These symptoms indicate: A. Low-grade NHL B. Indolent lymphoma C. B symptoms, suggesting an aggressive lymphoma D. Localized disease with an excellent prognosis
C. B symptoms, suggesting an aggressive lymphoma Rationale: B symptoms (fever >38°C, night sweats, weight loss >10% in 6 months) indicate more aggressive NHL subtypes.
83
8. Which aggressive form of NHL frequently presents as a rapidly enlarging mass? A. Diffuse Large B-cell Lymphoma (DLBCL) B. Follicular Lymphoma C. Small Lymphocytic Lymphoma (SLL) D. Marginal Zone Lymphoma
A. Diffuse Large B-cell Lymphoma (DLBCL) Rationale: DLBCL is an aggressive lymphoma that often presents as a rapidly growing mass, commonly extranodal.
84
9. What is the gold standard for diagnosing NHL? A. Peripheral blood smear B. Bone marrow biopsy C. Lymph node biopsy D. Serum electrophoresis
C. Lymph node biopsy Rationale: Lymph node biopsy is required for definitive diagnosis and classification of NHL subtypes.
85
10. Which of the following translocations is associated with Follicular Lymphoma? A. t(8;14) MYC translocation B. t(14;18) BCL2 translocation C. t(11;14) Cyclin D1 translocation D. del(17p)
B. t(14;18) BCL2 translocation Rationale: Follicular lymphoma is characterized by the t(14;18) translocation, leading to BCL2 overexpression, which prevents apoptosis.
86
11. Burkitt’s lymphoma is characterized by which genetic translocation? A. t(14;18) BCL2 translocation B. t(11;14) Cyclin D1 translocation C. t(8;14) MYC translocation D. t(9;22) BCR-ABL1
C. t(8;14) MYC translocation Rationale: Burkitt’s lymphoma is driven by the t(8;14) MYC translocation, leading to rapidly proliferating tumor growth.
87
12. Which of the following is the first-line chemotherapy regimen for aggressive NHL, including DLBCL? A. ABVD B. R-CHOP C. FCR D. Methotrexate
B. R-CHOP Rationale: R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) is the standard first-line regimen for aggressive B-cell NHLs.
88
13. In patients with relapsed or refractory NHL, which of the following advanced therapies may be considered? A. CAR-T cell therapy B. Tyrosine kinase inhibitors C. Hydroxyurea D. Low-dose steroids
A. CAR-T cell therapy Rationale: CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) is used for refractory or relapsed aggressive NHL.
89
1. Hodgkin’s lymphoma (HL) is characterized by which of the following epidemiological patterns? A. Occurs primarily in children under 5 years old B. Has a bimodal age distribution C. More common in women than men D. Has an equal incidence across all age groups
B. Has a bimodal age distribution Rationale: HL exhibits a bimodal age distribution, with peaks in young adults (15-30 years) and the elderly (>55 years).
90
3. Which virus is found in ~40% of Hodgkin’s lymphoma cases and is strongly associated with the mixed cellularity subtype? A. Human T-cell Leukemia Virus-1 (HTLV-1) B. Epstein-Barr Virus (EBV) C. Hepatitis C Virus (HCV) D. Human Papillomavirus (HPV)
B. Epstein-Barr Virus (EBV) Rationale: EBV infection is linked to ~40% of HL cases, particularly mixed cellularity HL, and is more common in HIV-positive individuals.
91
4. Which of the following conditions is associated with an increased risk of developing Hodgkin’s lymphoma? A. Type 1 Diabetes Mellitus B. Systemic Lupus Erythematosus C. HIV/AIDS D. Ulcerative Colitis
C. HIV/AIDS Rationale: HIV/AIDS increases the risk of developing HL, particularly mixed cellularity HL.
92
5. Which subtype of Hodgkin’s lymphoma is the most common? A. Mixed Cellularity HL (MCHL) B. Nodular Sclerosis HL (NSHL) C. Lymphocyte-Rich HL (LRHL) D. Lymphocyte-Depleted HL (LDHL)
B. Nodular Sclerosis HL (NSHL) Rationale: NSHL is the most common subtype (~70%) and frequently presents with a mediastinal mass in young adults.
93
10. Which characteristic cell type is seen in Hodgkin’s lymphoma? A. Auer rods B. Reed-Sternberg cells C. Smudge cells D. Sézary cells
B. Reed-Sternberg cells Rationale: Reed-Sternberg cells (binucleated "Owl’s eye" cells) are pathognomonic for Hodgkin’s lymphoma.
94
11. A patient with HL has lymph node involvement in both the cervical and axillary regions on the same side of the diaphragm. What is the correct Ann Arbor stage? A. Stage I B. Stage II C. Stage III D. Stage IV
B. Stage II Rationale: Stage II HL involves two or more lymph node regions on the same side of the diaphragm.
95
12. What is the first-line chemotherapy regimen for Hodgkin’s lymphoma? A. CHOP B. BEACOPP C. ABVD D. R-CHOP
C. ABVD Rationale: ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine) is the standard first-line regimen for HL.
96
13. Which treatment is used for relapsed or refractory HL that is CD30-positive? A. Rituximab B. Ibrutinib C. Brentuximab Vedotin D. Venetoclax
C. Brentuximab Vedotin Rationale: Brentuximab Vedotin (anti-CD30 monoclonal antibody) is used in relapsed HL cases.
97
14. Which of the following factors is associated with a poor prognosis in Hodgkin’s lymphoma? A. Stage I or II disease B. Absence of B symptoms C. Age >45 years D. Female sex
C. Age >45 years Rationale: Older age (>45), male sex, B symptoms, and advanced-stage disease are poor prognostic factors.
98
15. What is the most common cause of death in long-term survivors of Hodgkin’s lymphoma? A. Richter’s transformation B. Treatment-related toxicity (e.g., secondary malignancies, cardiac disease) C. Disease progression D. Opportunistic infections
B. Treatment-related toxicity (e.g., secondary malignancies, cardiac disease) Rationale: Long-term survivors of HL are at risk of secondary malignancies (e.g., lung or breast cancer) and cardiotoxicity from chemotherapy/radiation.
99
1. Which of the following statements regarding hemophilia is true? A. Hemophilia A is due to Factor IX deficiency. B. Hemophilia B is more common than Hemophilia A. C. Hemophilia is an autosomal dominant disorder. D. Hemophilia A is the most common inherited coagulation disorder affecting males.
D. Hemophilia A is the most common inherited coagulation disorder affecting males. Rationale: Hemophilia A (Factor VIII deficiency) accounts for 80% of all hemophilia cases and follows an X-linked recessive inheritance, primarily affecting males.
100
3. Which of the following is the most common site of spontaneous bleeding in severe hemophilia? A. Gastrointestinal tract B. Joints (hemarthrosis) C. Lungs D. Skin and mucous membranes
B. Joints (hemarthrosis) Rationale: Recurrent hemarthrosis (bleeding into joints) is the most common feature of severe hemophilia, particularly in the knees, elbows, and ankles.
101
5. A patient with hemophilia A presents with a large, painful swelling in the iliopsoas region after mild trauma. Which of the following is the most appropriate next step? A. Perform a lumbar puncture B. Give Factor VIII replacement therapy C. Start aspirin for pain relief D. Observe and re-evaluate in 24 hours
B. Give Factor VIII replacement therapy Rationale: Iliopsoas hematomas can cause femoral nerve compression, leading to neurologic deficits. Prompt Factor VIII replacement is essential to prevent complications.
102
6. A patient with hemophilia is suspected to have a bleeding disorder. Which coagulation test result is expected? A. Normal PT, prolonged aPTT B. Prolonged PT, normal aPTT C. Prolonged PT and aPTT D. Normal PT and aPTT
A. Normal PT, prolonged aPTT Rationale: Hemophilia (Factor VIII or IX deficiency) leads to a prolonged aPTT, while PT remains normal because the extrinsic pathway is unaffected.
103
7. A mixing study is performed on a patient with prolonged aPTT. The test result shows correction of the aPTT after mixing normal plasma. What does this indicate? A. Factor inhibitor (e.g., acquired hemophilia) B. Factor deficiency (e.g., hemophilia A or B) C. Vitamin K deficiency D. Disseminated Intravascular Coagulation (DIC)
B. Factor deficiency (e.g., hemophilia A or B) Rationale: In factor deficiencies (e.g., hemophilia A/B), a mixing study corrects the aPTT, confirming the absence of an inhibitor.
104
8. Which test is most specific for diagnosing hemophilia A? A. Bleeding time B. Platelet count C. Factor VIII activity level D. D-dimer test
C. Factor VIII activity level Rationale: Factor VIII activity measurement confirms hemophilia A, while Factor IX activity confirms hemophilia B. HEMOPHILIA A = 8 HEMOPHILIA B = 9
105
1. What is the most common inherited bleeding disorder? A. Hemophilia A B. Von Willebrand Disease (VWD) C. Factor V Leiden D. Antithrombin III Deficiency
B. Von Willebrand Disease (VWD) Rationale: VWD is the most common inherited bleeding disorder, affecting approximately 1% of the population.
106
2. What is the inheritance pattern of most cases of von Willebrand disease (VWD)? A. Autosomal recessive B. Autosomal dominant C. X-linked recessive D. X-linked dominant
B. Autosomal dominant Rationale: VWD is primarily autosomal dominant, affecting both genders equally. However, Type 3 VWD (severe form) follows autosomal recessive inheritance.
107
3. Which type of von Willebrand disease (VWD) is the most common? A. Type 1 B. Type 2A C. Type 2B D. Type 3
A. Type 1 Rationale: Type 1 VWD is the most common (75% of cases) and is due to a partial quantitative deficiency of von Willebrand factor (VWF), leading to mild bleeding.
108
5. Which type of von Willebrand disease is the most severe and results in a near absence of VWF? A. Type 1 B. Type 2A C. Type 2B D. Type 3
D. Type 3 Rationale: Type 3 VWD is rare but the most severe due to complete absence of von Willebrand factor, leading to severe bleeding similar to hemophilia.
109
6. Which of the following is the most common symptom in von Willebrand disease (VWD)? A. Spontaneous joint bleeding B. Mucocutaneous bleeding (epistaxis, menorrhagia, easy bruising) C. Hemoptysis D. Deep muscle hematomas
B. Mucocutaneous bleeding (epistaxis, menorrhagia, easy bruising) Rationale: VWD primarily causes mucocutaneous bleeding (epistaxis, menorrhagia, easy bruising), unlike hemophilia, which presents with deep tissue bleeding (e.g., hemarthrosis).
110
7. A 23-year-old woman with von Willebrand disease has heavy menstrual bleeding (menorrhagia). What is the most appropriate first-line treatment? A. Tranexamic acid B. Aspirin C. Warfarin D. Heparin
A. Tranexamic acid Rationale: Tranexamic acid (an antifibrinolytic) is useful for menorrhagia in VWD by stabilizing clots and reducing excessive bleeding.
111
8. A patient with von Willebrand disease undergoes dental extraction and experiences prolonged bleeding. What is the best initial treatment? A. Fresh Frozen Plasma B. Desmopressin (DDAVP) C. Warfarin D. Clopidogrel
B. Desmopressin (DDAVP) Rationale: Desmopressin (DDAVP) increases von Willebrand factor (VWF) release from endothelial cells and is the first-line treatment for mild to moderate VWD in minor procedures.
112
9. Which of the following is typically abnormal in von Willebrand disease? A. PT (Prothrombin Time) B. aPTT (Activated Partial Thromboplastin Time) C. Platelet count D. D-dimer
B. aPTT (Activated Partial Thromboplastin Time) Rationale: aPTT may be prolonged in VWD, especially if Factor VIII levels are low, since VWF stabilizes Factor VIII. PT remains normal.
113
1. Which of the following is the most common cause of disseminated intravascular coagulation (DIC)? A. Trauma B. Malignancy C. Sepsis (Gram-negative bacteria) D. Snake bites
C. Sepsis (Gram-negative bacteria) Rationale: Sepsis, particularly Gram-negative bacterial infections, is the most common trigger of DIC due to endotoxin-induced activation of the coagulation cascade.
114
2. A pregnant woman develops acute respiratory distress and sudden coagulopathy after delivery. Which of the following conditions is the most likely cause of DIC in this setting? A. Placenta previa B. Preeclampsia C. Amniotic fluid embolism D. Ectopic pregnancy
C. Amniotic fluid embolism Rationale: Obstetric causes of DIC include amniotic fluid embolism, placental abruption, and retained dead fetus syndrome.
115
3. A patient with acute DIC is most likely to present with which of the following symptoms? A. Spontaneous hemarthrosis B. Isolated deep vein thrombosis (DVT) C. Widespread bleeding and organ failure D. Hemiparesis and facial droop
C. Widespread bleeding and organ failure Rationale: Acute DIC leads to severe bleeding (petechiae, ecchymosis, GI/CNS hemorrhage) and microvascular thrombosis, which can cause multi-organ failure.
116
4. Chronic DIC is most commonly associated with which of the following conditions? A. Acute myeloid leukemia (AML) B. Malignancy (e.g., solid tumors) C. Sepsis D. Obstetric complications
B. Malignancy (e.g., solid tumors) Rationale: Chronic DIC is most commonly seen in malignancies, where thrombosis predominates over bleeding.
117
5. Which of the following laboratory findings is most suggestive of DIC? A. Normal PT and PTT, low platelet count B. Prolonged PT and PTT, low fibrinogen, elevated D-dimer C. Increased platelet count, normal fibrinogen, normal PT and PTT D. Normal PT and PTT, normal fibrinogen, normal D-dimer
B. Prolonged PT and PTT, low fibrinogen, elevated D-dimer Rationale: DIC is characterized by prolonged PT and PTT, thrombocytopenia, decreased fibrinogen, and elevated D-dimer due to excessive clotting and fibrinolysis.
118
6. Which of the following is considered the best marker for diagnosing DIC? A. Platelet count B. D-dimer C. Prothrombin time (PT) D. Factor VIII level
B. D-dimer Rationale: D-dimer is the most sensitive marker for DIC, reflecting excess fibrinolysis due to ongoing clot breakdown.
119
7. A blood smear in a patient with DIC is most likely to show which of the following findings? A. Target cells B. Schistocytes (fragmented RBCs) C. Heinz bodies D. Spherocytes
B. Schistocytes (fragmented RBCs) Rationale: Schistocytes (helmet cells) are seen due to microangiopathic hemolytic anemia (MAHA) caused by fibrin deposition in small vessels.
120
9. A patient with DIC and severe thrombocytopenia (<20,000/µL) is experiencing significant bleeding. What is the next best step? A. Platelet transfusion B. Heparin infusion C. IV antibiotics only D. Warfarin therapy
A. Platelet transfusion Rationale: Platelet transfusion is indicated in DIC when platelet counts are <20,000/µL with active bleeding.
121
1. What is the most common acute leukemia in adults? A. Acute Myeloid Leukemia (AML) B. Acute Lymphoblastic Leukemia (ALL) C. Chronic Myeloid Leukemia (CML) D. Chronic Lymphocytic Leukemia (CLL)
A. Acute Myeloid Leukemia (AML) Rationale: AML is the most common acute leukemia in adults, accounting for 31% of all new acute leukemia cases.
122
3. Which of the following increases the risk of developing AML? A. Clonal hematopoiesis of indeterminate potential (CHIP) B. Smoking C. Prior chemotherapy (alkylating agents, topoisomerase II inhibitors) D. All of the above
D. All of the above Rationale: AML risk is increased by CHIP mutations (DNMT3A, TET2, ASXL1), environmental exposures (smoking, benzene), and prior chemotherapy.
123
4. Which of the following is a known cytotoxic chemotherapy agent associated with therapy-related AML? A. Methotrexate B. Alkylating agents and topoisomerase II inhibitors C. Tyrosine kinase inhibitors D. Corticosteroids
B. Alkylating agents and topoisomerase II inhibitors Rationale: Prior chemotherapy, particularly alkylating agents (e.g., cyclophosphamide) and topoisomerase II inhibitors (e.g., etoposide), increases the risk of therapy-related AML.
124
5. Which of the following is a hallmark sign of acute myeloid leukemia (AML)? A. Pancytopenia with circulating myeloblasts B. Hypercalcemia C. Smudge cells on peripheral smear D. Lytic bone lesions
A. Pancytopenia with circulating myeloblasts Rationale: AML is characterized by bone marrow failure leading to anemia, thrombocytopenia, and neutropenia, often with circulating myeloblasts.
125
6. Which subtype of AML is associated with gingival hyperplasia? A. Acute Promyelocytic Leukemia (APL) B. Monocytic AML C. Megakaryoblastic AML D. Therapy-related AML
B. Monocytic AML Rationale: Monocytic AML (M5 subtype) frequently presents with gingival hyperplasia due to tissue infiltration.
126
7. What is the hallmark finding on peripheral blood smear in AML? A. Smudge cells B. Auer rods in myeloblasts C. Bite cells D. Target cells
B. Auer rods in myeloblasts Rationale: Auer rods (needle-like inclusions in myeloblasts) are specific for AML.
127
16. What is the most common cause of death in AML? A. Cardiac arrhythmia B. Infections (bacterial, fungal sepsis) C. Pulmonary embolism D. Stroke
B. Infections (bacterial, fungal sepsis) Rationale: Severe neutropenia in AML leads to life-threatening infections, the most common cause of death.
128
5. Which of the following is the most common physical finding in CML? A. Hepatomegaly B. Lymphadenopathy C. Splenomegaly D. Skin rash
C. Splenomegaly Rationale: Splenomegaly is the most common physical finding in CML and is often associated with early satiety due to splenic enlargement.
129
7. A patient with suspected CML undergoes a CBC. What is the most characteristic laboratory finding? A. Pancytopenia B. Marked leukocytosis (>100,000 WBC/µL) C. Thrombocytopenia D. Increased lymphocytes
B. Marked leukocytosis (>100,000 WBC/µL) Rationale: CML is characterized by marked leukocytosis with left-shifted granulocytosis, including neutrophils, basophils, and eosinophils.
130
8. Which of the following findings on peripheral blood smear is most suggestive of CML? A. Auer rods B. Smudge cells C. Left shift with myelocytes and metamyelocytes D. Howell-Jolly bodies
C. Left shift with myelocytes and metamyelocytes Rationale: CML presents with a "left shift", meaning an increased number of immature myeloid precursors, including myelocytes and metamyelocytes.
131
9. What percentage of CML cases are diagnosed in the chronic phase? A. 30% B. 50% C. 90% D. 100%
C. 90% Rationale: Most CML cases (~90%) are diagnosed in the chronic phase, characterized by leukocytosis and splenomegaly with <10% blasts in the bone marrow.
132
10. What is the defining feature of blast crisis in CML? A. Platelet count >1,000,000/µL B. Splenomegaly C. Blasts ≥20% in peripheral blood or bone marrow D. Leukocytosis >50,000 WBC/µL
C. Blasts ≥20% in peripheral blood or bone marrow Rationale: Blast crisis is defined as ≥20% blasts in the blood or bone marrow, resembling acute leukemia (AML or ALL).
133
11. What is the first-line treatment for CML? A. Chemotherapy B. Corticosteroids C. Tyrosine kinase inhibitors (TKIs) D. Hematopoietic stem cell transplant
C. Tyrosine kinase inhibitors (TKIs) Rationale: TKIs, such as Imatinib, are first-line therapy for CML and target the BCR-ABL1 oncoprotein.
134